Free Trial
→ [Urgent] Hedge Funds Expect Major Crypto Moves (From Crypto 101 Media) (Ad) Free CTVA Stock Alerts

Corteva (CTVA) Stock Forecast & Price Target

$52.44
-0.04 (-0.08%)
(As of 07/5/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends

Corteva - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 22 Analyst Ratings

Consensus Price Target

$63.00
20.14% Upside
High Forecast$74.00
Average Forecast$63.00
Low Forecast$52.00
TypeCurrent Forecast
7/7/23 to 7/6/24		1 Month Ago
6/7/23 to 6/6/24		3 Months Ago
4/8/23 to 4/7/24		1 Year Ago
7/7/22 to 7/7/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
15 Buy rating(s)
15 Buy rating(s)
16 Buy rating(s)
15 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
5 Hold rating(s)
4 Hold rating(s)
Sell
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$63.00$63.05$63.14$72.59
Forecasted Upside20.14% Upside18.39% Upside21.52% Upside17.47% Upside

CTVA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CTVA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Corteva Stock vs. The Competition

TypeCortevaConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.64
2.44
2.50
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside20.14% Upside782.83% Upside12.26% Upside
News Sentiment RatingVery Positive News
Positive News
Positive News
Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/18/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy ➝ Buy$61.00 ➝ $60.00+15.27%
6/12/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Buy$65.00 ➝ $65.00+25.90%
6/7/2024OTR Global
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingMixed ➝ Negative
5/6/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOutperform ➝ Outperform$62.00 ➝ $64.00+12.89%
5/3/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOverweight ➝ Overweight$66.00 ➝ $67.00+17.21%
5/3/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy ➝ Buy$60.00 ➝ $65.00+13.72%
50-year Wall Street Legend Issues July Stock Warning (Ad)

July is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks – including NVDA – stumbling?

To see this July stock warning for yourself – 100% free – click here.
5/3/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOutperform ➝ Outperform$64.00 ➝ $67.00+17.13%
5/3/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOutperform ➝ Outperform$67.00 ➝ $69.00+21.52%
4/12/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOverweight ➝ Neutral$58.00 ➝ $57.00+0.96%
4/10/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetEqual Weight ➝ Equal Weight$55.00 ➝ $58.00+1.42%
4/9/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOverweight ➝ Overweight$63.00 ➝ $66.00+14.74%
3/1/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOutperform$67.00+25.30%
2/12/2024Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeHold ➝ Buy$57.00 ➝ $65.00+21.27%
2/2/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeUnderperform ➝ Neutral$53.00-1.96%
1/11/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy ➝ Buy$65.00 ➝ $64.00+38.77%
11/27/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeBuy ➝ Hold$63.00 ➝ $52.00+11.42%
11/22/2023Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy ➝ Buy$82.00 ➝ $63.00+36.45%
11/10/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOverweight ➝ Overweight$80.00 ➝ $60.00+37.77%
10/24/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetNeutral ➝ Neutral$65.00 ➝ $56.00+15.08%
8/17/2023Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy ➝ Buy$78.00 ➝ $68.00+35.97%
8/4/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingOutperform ➝ Outperform$74.00+31.95%
7/25/2023Redburn Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeBuy ➝ Neutral
5/22/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingUpgrade
5/22/2023Vertical Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeHold ➝ Buy$67.00+17.61%
2/3/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy$72.00 ➝ $74.00+19.35%
1/11/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeUnderperform ➝ Neutral$64.00 ➝ $68.00+10.12%
8/8/2022Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeNeutral ➝ Buy$67.00 ➝ $74.00+27.81%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 08:34 AM ET.

CTVA Forecast - Frequently Asked Questions

What is Corteva's forecast for 2024?

According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Corteva is $63.00, with a high forecast of $74.00 and a low forecast of $52.00.

Should I buy or sell Corteva stock right now?

22 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Corteva in the last twelve months. There is currently 1 sell rating, 6 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CTVA shares.

Does Corteva's stock price have much upside?

According to analysts, Corteva's stock has a predicted upside of 19.07% based on their 12-month stock forecasts.

What analysts cover Corteva?

Corteva has been rated by research analysts at Barclays, BMO Capital Markets, Canaccord Genuity Group, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., KeyCorp, Mizuho, Oppenheimer, OTR Global, Royal Bank of Canada, and Wells Fargo & Company in the past 90 days.

Do Wall Street analysts like Corteva more than its competitors?

Analysts like Corteva more than other "consumer staples" companies. The consensus rating for Corteva is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CTVA compares to other companies.


Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NYSE:CTVA) was last updated on 7/6/2024 by MarketBeat.com Staff

From Our Partners
Why Conservative Americans Are Turning to Gold in 2024
Welcome to the financial rollercoaster of 2024, where inflation is relentless, stock markets are inflated, and...
All American Assets | Sponsored
50-year Wall Street Legend Issues July Stock Warning
July is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...
Chaikin Analytics | Sponsored
Biden to drop out; finish out his term?
On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...
Paradigm Press | Sponsored
Write this ticker symbol down…
A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...
StocksToTrade | Sponsored
Bill Gates is all about this tiny $2 stock
What does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthles...
Timothy Sykes | Sponsored
Silver Expected for Extreme Price Action
Our newest Silver Investing Guide reveals how savvy investors are capitalizing on silver's continued rise – PL...
Colonial Metals | Sponsored
1k a day while computer does all work?
What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...
Digital Mavericks Media | Sponsored
"The Biggest Drug Ever" Is Coming
UBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Phar...
Behind the Markets | Sponsored